Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis

Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis

Peritoneal dialysis (PD) is an important renal replacement therapy for end-stage renal disease (ESRD) patients. However, its complications, such as peritoneal fibrosis (PF) and angiogenesis can cause ultrafiltration failure and PD termination. Histone deacetylase 6 (HDAC6) has been demonstrated to b...

Full description

Bibliographic Details
Main Authors: Yingfeng Shi, Jun Ni, Min Tao, Xiaoyan Ma, Yi Wang, Xiujuan Zang, Yan Hu, Andong Qiu, Shougang Zhuang, Na Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Renal Failure
Subjects:
histone deacetylase 6
peritoneal fibrosis
peritoneal dialysis
angiogenesis
vascular endothelial growth factor
Online Access:http://dx.doi.org/10.1080/0886022X.2020.1811119

Internet

http://dx.doi.org/10.1080/0886022X.2020.1811119

Similar Items